Background-In patients with possible acute coronary syndromes, guidelines recommend routine provocative testing after negative cardiac biomarkers. We hypothesized that myocardial perfusion imaging would be low yield with limited shortterm value and that early revascularization would not affect mortality. Methods and Results-We identified consecutive patients referred from our emergency department between October 2004 and September 2011 who had myocardial perfusion imaging after negative troponin T tests and nondiagnostic ECGs.
O ver 7 million patients present to emergency departments (ED) in the United States every year with a principal complaint of chest pain. 1 Most of these patients will not be diagnosed with an acute coronary syndrome (ACS), but the morbidity and legal consequences associated with a missed diagnosis of myocardial infarction (MI) are significant. 2 Consequently, for patients with possible ACS, serial negative cardiac biomarkers, and nondiagnostic ECGs, the guidelines recommend routine provocative testing or an assessment for anatomic coronary artery disease (CAD) before discharge for most patients and within 72 hours of discharge for low-risk patients. If the test reveals evidence of inducible ischemia, the guidelines endorse subsequent hospitalization. 3, 4 Clinical Perspective on p 919
Despite these recommendations, there is little data to suggest that inpatient admission and treatment after abnormal myocardial perfusion imaging (MPI) in a low-risk population improve outcomes. Furthermore, the benefit of an early revascularization strategy in low-risk ACS is uncertain. 5 The current clinical practice to admit patients from the ED with a positive stress test is based on the assumption that the presence of myocardial ischemia reclassifies patients from low risk to high risk for short-term adverse events, thus justifying early revascularization. This assumption is unproven and has been questioned. 6 Accordingly, we conducted this study to define further the yield of rest-stress single photon emission computed tomography (SPECT) MPI to detect ischemia in patients referred from the ED after serial negative troponin T testing and nondiagnostic ECGs. In addition, we assessed short-term adverse events after MPI. Finally, we investigated whether patients with ischemia realize a survival benefit with early revascularization.
Methods

Study Population
At a single urban medical center, we identified 5354 consecutive patients who were referred from the ED observation unit for reststress treadmill or pharmacologic SPECT MPI from October 2004 through September 2011. According to our laboratory protocol, patients undergoing MPI must have ≥2 negative troponin T tests ≥6 hours apart and <1 mm resting ST depression, no ST elevation, and no new left bundle branch blocks on ECG. Isolated T wave inversions were permissible for testing. Before testing, ECG and clinical history were reviewed by a cardiology fellow or attending cardiologist. A Roche fourth generation electrochemiluminescence immunoassay conventional troponin T assay was used with an upper limit of normal defined by our laboratory as <0.04 ng/mL. All troponin T tests (P.C.) and 20% of ECGs (P.C., S.K.) were reviewed, and no cases of inappropriate stress MPI were identified. At the time of stress testing, patient demographic, comorbidities, and medications are prospectively entered into a stress database. Hypertension was defined as self-reported history or use of antihypertensive medications. Hyperlipidemia was defined as an abnormal fasting lipid panel according to ATP III guidelines, self-reported history, or use of lipid lowering medications. Diabetes mellitus was defined as fasting blood glucose ≥126 mg/dL, self-reported history, or use of glucose-lowering medications. Obesity was defined as a body mass index >30. Two authors (P.C., S.K.) initially blinded to MPI and coronary angiography results, and then reviewed this information and medical records to calculate thrombolysis in myocardial infarction (TIMI) scores. 7 Chest pain was not prospectively characterized, and most patients with symptoms considered an anginal equivalent were referred from our ED for rest-stress MPI. Two authors (P.C., S.K.) retrospectively reviewed charts to adjudicate severe chest pain according to the TIMI definition. 7 For the parameter of prior coronary stenosis >50%, a history of MI or coronary revascularization was also included as has been previously performed in ED populations. 8 
Stress Testing
Exercise stress testing with MPI was performed in patients who were able to exercise adequately. Heart rate and blood pressure were recorded, and exercise capacity was estimated in metabolic equivalents. Patients who were unable to exercise underwent a pharmacologic stress test with either adenosine or regadenoson. SPECT images were acquired in accordance with the American Society of Nuclear Cardiology Guidelines for gated single day technetium-99m tracer protocols. 9 Briefly, gated SPECT MPI was obtained at rest (low dose ≈9-15 mCi) and stress (high dose ≈30-45 mCi) using Tc-99m tetrofosmin. Imaging was performed using a dual-headed detector gamma camera with high-resolution, low-energy collimators. Images were reviewed by the nuclear technologist and physician before patient discharge to determine whether repeat imaging with attenuation correction was needed. A 17-segment model of the left ventricle was used to semiquantitatively score rest and stress perfusion images using standard software (4D-MSPECT, University of Michigan Medical Center, Ann Arbor, MI). The summed stress score and summed rest score were obtained by adding the scores on the respective images. The summed difference score (SDS) was calculated by subtracting the summed rest score from the summed stress score. The SDS was used to represent the amount of ischemia with the percent ischemic myocardium expressed as SDS divided by 68. 10 The left ventricular ejection fraction (EF) was calculated from stress gated images. All tests were reviewed by a nuclear medicine physician or cardiologist who was aware of patient data.
Invasive Coronary Angiography and Revascularization
Results of coronary angiography within 30 days of MPI were obtained from our cardiac catheterization database. Obstructive CAD was defined angiographically as a left main stenosis ≥50% or a stenosis ≥70% in any major artery or branch. Coronary anatomy was determined from the report of the diagnostic coronary angiogram (P.C., S.K.). For patients with prior coronary artery bypass grafting, obstructive CAD was defined as a ≥70% stenosis in a native coronary artery that was either not supplied by a bypass graft or if the bypass graft also had a ≥70% stenosis. Early coronary revascularization was determined if a diagnostic angiogram within 30 days of MPI resulted in downstream balloon angioplasty, stenting, or coronary artery bypass grafting .
Outcomes
Outcome measures included all-cause mortality, as assessed by the Social Security Death Index, abnormal MPI results, and revascularization. The accession date for the Social Security Death Index was November 1, 2011. Administrative censoring was performed for patients that were not deceased with a censor date of November 1, 2011. Early events at other medical centers were not collected, and the minimum follow-up was 1 month. MPI was considered abnormal if the EF was <45% or if there were any perfusion defects not attributed to artifact. Mild to moderate ischemia was defined as 5%-10% ischemic myocardium, and moderate to severe ischemia was defined as >10% ischemic myocardium.
Statistical Analysis
Statistical analyses were performed with JMP Version 10 (SAS Institute Inc, Cary, NC) and Stata Version 13.1 (StataCorp, College Station, TX). Normally distributed continuous variables were expressed as means with SDs, whereas non-normal continuous variables were expressed as medians with interquartile ranges. Categorical variables were expressed as percentages and totals. Intergroup comparisons were performed using Fisher Exact, t, or Wilcoxon ranksum tests, as appropriate. A Tukey-Kramer honestly significant difference test was used to mitigate against type I error with multiple comparisons. Cox proportional hazard modeling was performed to assess variables associated with survival time free of all-cause mortality, and the proportionality of hazards assumption was satisfied. Survival analysis was conducted with the Kaplan-Meier method, and statistical comparisons were made using the log-rank test. A propensity model was created using nonparsimonious logistic regression to summarize factors associated with referral to revascularization. Patients with >5% ischemic myocardium were matched according to propensity scores with a case-to-control (revascularization-to-non-revascularization) ratio of 1:1. The final propensity score included age, sex, body mass index, pharmacologic test, severe chest pain, known CAD, hypertension, hyperlipidemia, diabetes mellitus, current smoking, family history of CAD, aspirin use, maximum heart rate, metabolic equivalents, heart rate recovery, SDS, and EF. An interactional variable was also included to account for a significant interaction between body mass index and the use of a pharmacologic test. To avoid collinearity, SDS was used in the model instead of summed stress score, and EF was used instead of summed rest score. The c statistic of the propensity score for revascularization was 0.93. Standardized bias was compared between unmatched and matched groups. For all tests, a 2-sided P<0.05 was considered statistically significant. Our institutional review board approved this study.
Results
Patient Characteristics
In a cohort of 5354 patients followed for 3.4±1.9 years, the mean age was 59, and 58.7% (3144) were female (Table 1) . Risk factors included known CAD in 23.1% (1235) and diabetes mellitus in 25.6% (1369). Presenting symptoms were chest pain in 83.8% (4485) and dyspnea in 30.2% (1616). Most patients had low-risk TIMI scores: 58.8% had a TIMI score of 0 or 1 (3147) and 19.9% (1064) had a TIMI score of 2. Intermediate to high TIMI scores were less common: 14.3% (768) had a TIMI score of 3 and 7% (375) had a TIMI score of 4 or 5.
Yield of SPECT MPI for Detecting Ischemia
Abnormal MPI was present in 19.7% (1055) of patients. The ischemic burden was >5% in 9% (479) of patients and >10% in 3.6% (193) of patients ( Figure 1 ). The incidence and magnitude of ischemic myocardium increased with increasing TIMI scores ( Figure 2 ). The yield of MPI in detecting inducible ischemia was low in patients with low TIMI scores: 4.9% (154) of patients with TIMI scores of 0 or 1 and 9.5% (101) of patients with TIMI scores of 2 had ≥5% ischemic myocardium. Conversely, 19.6% (224) of patients with TIMI scores ≥3 had ≥5% ischemic myocardium. The yield was also low for detecting moderate to severe ischemia in patients with low TIMI scores and modest in patients with intermediate to high TIMI scores: 2.3% (98) of patients with TIMI scores ≤2 had >10% ischemic myocardium and 8.3% (95) of patients with TIMI scores ≥3 had >10% ischemic myocardium (P<0.001). Expressed as mean±SD, median with interquartile ranges, or percentage (n). ACEi indicates angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; CAD, coronary artery disease; METs, estimated metabolic equivalents; MPI, myocardial perfusion imaging; SBP, systolic blood pressure; and TIMI, thrombolysis in myocardial infarction.
*Two or more typical anginal episodes in previous 24 h.
Downstream Invasive Coronary Angiography and Obstructive CAD
Invasive coronary angiography was performed in 9.9% (530) of patients within 30 days of MPI, and 47.7% (253) of these patients had angiographic obstructive CAD. Only 10.4 % (55) of patients with coronary angiography had obstructive CAD involving the left main trunk, all 3 major vessel territories, or proximal left anterior descending artery. Among patients with a normal MPI study, appropriately few underwent coronary angiography (1.2%, 50 patients), and 34% (17) of these patients had obstructive CAD. Conversely, most patients with >5% ischemic myocardium had coronary angiography (74.4%, 357 patients). Of these patients, 52.1% (186) had obstructive CAD (Figure 1 ) and 57.7% (206) had a coronary stenosis ≥50%. Therefore, even in patients with evidence of ischemia, significant angiographic CAD on subsequent coronary angiography was often absent. As expected, the presence and severity of obstructive CAD also increased with increasing TIMI scores. In the entire cohort, 1.9% (59) of patients with TIMI scores of 0-1, 4.6% (49) of patients with TIMI scores of 2, 10.3% (79) of patients with TIMI scores of 3, and 17.6% (66) of patients with TIMI scores of 4-5 had obstructive CAD (P<0.001 for trend). Overall, with regards to left main, 3 vessel, or proximal left anterior descending disease, the incidence for TIMI 0-1, TIMI 2, TIMI 3, and TIMI 4-5 were 0.4% (13), 1.5% (16), 1.7% (13), and 3.5% (13), respectively (P<0.001 for trend). Among patients who were referred for coronary angiography, the incidence of obstructive CAD also increased with increasing TIMI scores: 30.9% for TIMI 0-1, 43.4% for TIMI 2, 58.1% for TIMI 3, and 74.2% for TIMI 4-5 (P<0.001 or trend).
Short-Term Mortality and Early Revascularization
At 30 days, 7 patients were deceased (0.1%). The cause of death in 3 patients is unknown, 3 patients died from gastrointestinal malignancies, and 1 patient died from a stroke. A total of 187 patients (3.5%) had coronary revascularization, and 16 of these patients had normal MPI. There were 6 patients with normal MPI who returned with acute MI: 3 patients with STelevation MI and 3 with non-ST-elevation MI.
Patients with early revascularization were significantly older, more likely to be male, had more comorbid cardiovascular diagnoses, had lower EFs, and more severe perfusion defects (Table 1) . Among patients with ≥5% ischemic myocardium, early revascularization was associated with male sex, known CAD, hyperlipidemia, increasing TIMI scores, higher EFs, and more severe perfusion defects ( Table 2) . Among patients with TIMI 0-1, 1.6% (48) had revascularization, and 3.3% (35) of patients with TIMI 2 had revascularization. In contrast, patients with TIMI 3 and TIMI 4-5 had revascularization rates of 7.6% (58) and 12.3% (46), respectively (P≤0.01 between all groups; Figure 3 ).
Intermediate-Term Mortality and Early Revascularization
During 3.4±1.9 years of follow-up, 347 (6.5%) patients died including 21 (11.2%) patients with early revascularization. In a Cox proportional hazards model, the magnitude of inducible ischemia was associated with increased hazard of mortality in a univariable (hazard ratio [HR], 1.08; 95% confidence interval [CI], 1.05-1.11) but not a multivariable model that included clinical factors and EF (HR, 1.02; 95% CI, 1.02, 0.98-1.05). Increased EF, however, was associated with decreased hazard of mortality in univariable (HR, 0.96; 95% CI, 0.95-0.97) and multivariable models (HR, 0.97; 95% CI, 0.97-0.98). Among all patients, early revascularization was associated with increased mortality in a univariable analysis (HR, 1.79; 95% CI, 1.12-2.71), but there was no significant association in the multivariable model (HR, 1.09; 95% CI, 0.66-1.73; Table 3 ).
Among patients with at least >5% ischemic myocardium, revascularization was not associated with mortality in an unadjusted analysis ( Figure 4A ; HR, 0.84; 95% CI, 0.44-1.45). To address bias related to referral for revascularization, 141 of 144 patients with early revascularization and ≥5% ischemic myocardium were successfully matched (Table 4 ; Figure  I in the Data Supplement). Propensity-matched groups also showed no association between early revascularization and mortality ( Figure 4B ; HR, 1.00; 95% CI, 0.49-2.07). Percentage of patients with >5 but ≤10% ischemic myocardium (blue) and >10% ischemic myocardium (red), stratified by thrombolysis in myocardial infarction (TIMI) scores. *P value for >5 but ≤10% ischemic myocardium between groups; ‡P value for >10% ischemic myocardium between groups.
Discussion
Our large dataset enables us to assess the yield and short-term prognostic value of rest-stress MPI in patients presenting from the ED after negative troponins. We also investigated the relationship between MPI-guided early revascularization and mortality. There are a number of salient and clinically important observations. The overall group of patients who rule out for MI after presenting to the ED with possible ACS constitute a very low-risk population, and short-term adverse events are rare. In fact, many patients with atypical symptoms undergo stress testing, and many will have a noncardiac pathogenesis of chest pain. At 30 days, only 7 patients (0.1%) were deceased, mostly from noncardiac reasons, and 6 patients received revascularization for an acute MI. Using the TIMI risk score to stratify patients, we observed that the yield for detecting ischemia is low in patients with TIMI scores ≤2 (the majority of our cohort), with the incidence and magnitude of ischemia increasing with increasing clinical risk. In addition to risk stratification, MPI acts as a gatekeeper to invasive coronary angiography and subsequent revascularization. 4 In our cohort, MPI results were generally respected with regards to downstream testing and interventions. Only 1.2% of patients with normal MPI were sent for coronary angiography while 3 of every 4 patients with >5% ischemia had coronary angiography. In patients who had coronary angiography, Expressed as mean±SD, median with interquartile ranges, or percentage (n). ACEi indicates angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; CAD, coronary artery disease; METs, estimated metabolic equivalents; MPI, myocardial perfusion imaging; SBP, systolic blood pressure; and TIMI, thrombolysis in myocardial infarction.
*Two or more typical anginal episodes in previous 24 h. we observed a limited correlation between abnormal MPI and obstructive CAD. The low pretest probability of disease in this low-risk cohort almost certainly accounts for this finding. Therefore, based on the observed low yield to detect ischemia and obstructive CAD on angiography, MPI before discharge after 2 negative troponins should be considered only in patients with TIMI scores ≥3. The ultimate goal of the current strategy practiced in EDs or chest pain units is to identify patients at higher risk that will benefit from more aggressive inpatient and early invasive management. Our study tested this hypothesis by propensity matching patients with ischemia according to revascularization status. With over 3 years of follow-up, we failed to identify an association between early revascularization and decreased mortality in patients with inducible ischemia.
Previous Studies of Routine Provocative Testing to Risk Stratify Possible ACS After Negative Cardiac Biomarkers
Previous MPI studies in patients referred for routine provocative testing after negative cardiac biomarkers have demonstrated evidence of ischemia in 5.3% and 11.2% of patients. 11, 12 Our study demonstrated a similar yield with 9.0% of patients having ≥5% ischemic myocardium. Unlike these previous studies, a greater percentage of our patients with evidence of ischemia subsequently had invasive coronary angiography. Therefore, we were able to not only further elucidate the association among clinical risk, abnormal MPI, and obstructive CAD but could also comment on the impact of early revascularization when MPI results were used to guide further testing and interventions.
An additional strength of our study is the longer duration of follow-up. Previous studies with exercise testing and coronary computed tomographic angiography have also shown that abnormal results lead to increased detection of CAD and revascularization. 13, 14 Given the short duration of follow-up, it is unclear whether these interventions improved outcomes. In patients with stable coronary disease, a landmark randomized trial supported initial medical management, 15 and whether patients with moderate to severe ischemia benefit from revascularization is the focus of an ongoing randomized trial. 16 Most patients in our study had mild to moderate ischemia, and previous studies of patients with stable CAD have shown no benefit of revascularization in patients with this amount of ischemia. 17, 18 Based on our observations, most patients who present to the ED with chest pain syndromes, negative cardiac biomarkers, and nondiagnostic ECGs should be managed as outpatients with possible stable CAD and not as patients with possible ACS.
Evolving Use of Cardiac Biomarkers for Possible ACSs
When the morbidity and medicolegal hazard associated with a missed diagnosis of MI are discussed, the referenced literature often predates standard serial troponin measurements. 2, 19 Conventional troponin elevations reclassify Creatine Kinase-MB negative patients from unstable angina to non-ST-elevation MI. This reclassification is not simply semantic; it identifies patients at higher risk who benefit from more intensive treatment. 20 More recently, high-sensitivity troponin measurements have demonstrated effective risk stratification for patients presenting to the ED with possible ACS. 21 In a study of 8907 patients with a single negative high-sensitivity troponin, only 15 patients (0.17%) had a MI, and no patients died at 30 days. 22 Similarly, in our study, 7 patients died, the majority from noncardiac causes, and 6 patients had revascularization for an acute MI, yielding an adverse event rate of 0.24%. Furthermore, more sensitive troponin assays improve sensitivity but worsen specificity for a type I MI. 22 In patients with nondiagnostic ECGs and negative conventional serial troponins, the short-term prognosis is excellent, and the incremental value of a negative high-sensitivity troponin is uncertain. The adoption of high-sensitivity troponin in the United States could facilitate earlier discharge from the emergency room, but the decreased specificity may also result in more unnecessary downstream testing.
Limitations
Our study was retrospective from a single center urban ED. We do not know if patients presented to other institutions for invasive coronary angiography within 30 days of MPI, but we presume that this scenario is a rarity and may apply to a minority of patients. Our cohort was low risk with relatively few patients with intermediate to high-risk TIMI scores and few patients with greater than moderate to severe ischemia on MPI. The generalizability of our conclusions is limited for these patients. Furthermore, we may not have had adequate power to detect a difference in mortality with revascularization, although our cohort included over 5000 patients. These observations also highlight the difficulty in identifying higher risk patients with negative serial troponins, nondiagnostics ECGs, and resolved chest pain.
Conclusions
In patients referred for MPI from the ED after negative serial troponins and nondiagnostic ECGs, short-term adverse events are rare. Furthermore, the yield of MPI for detecting ischemia is low in patients with TIMI scores ≤2 and modest for patients with TIMI scores ≥3. Likewise, the yield of subsequent invasive coronary angiography to detect obstructive CAD is low in patients with TIMI scores of ≤2 and modest in patients with TIMI scores of ≥3. Finally, we are unable to demonstrate a survival benefit with early revascularization in patients with ischemia. These findings make it difficult to justify routine provocative testing for all patients presenting to the ED with chest pain. Selective provocative testing may be considered in patients with negative troponins and TIMI scores ≥3, although the benefit of intensive inpatient treatment and early revascularization in any patient with resolved chest pain, nondiagnostic ECGs, and negative serial troponins is uncertain.
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